Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • The so-call third-generation sequencing coming, but is it credible?

    Hi all,

    I just read the following paper named Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays from Science Express. In this paper, a sequencing corporation, Complete Genomics, Inc., located at Mountain View, CA announced they will release the so-called third-generation sequecing technology with high coverage (45- to 87-fold coverage per genome) and very low price ($4,400). I was attracted deeply by this paper but with suspicion on this. So I try to contact with this corporation using its service email. But it's unfortunate that I have got any response even though 3 emails were sent until now. So I attach the abstract of this paper here and hope you can perform a evaluation on this so-called new technology. Thank you.

    Regards,

    Wuhoucdc

    PS: Published Online November 5, 2009
    Science DOI: 10.1126/science.1181498
    Science Express Index

    Reports
    Submitted on September 3, 2009
    Accepted on October 23, 2009



    Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays
    Radoje Drmanac 1*, Andrew B. Sparks 1, Matthew J. Callow 1, Aaron L. Halpern 1, Norman L. Burns 1, Bahram G. Kermani 1, Paolo Carnevali 1, Igor Nazarenko 1, Geoffrey B. Nilsen 1, George Yeung 1, Fredrik Dahl 2, Andres Fernandez 1, Bryan Staker 1, Krishna P. Pant 1, Jonathan Baccash 1, Adam P. Borcherding 1, Anushka Brownley 1, Ryan Cedeno 1, Linsu Chen 1, Dan Chernikoff 1, Alex Cheung 1, Razvan Chirita 1, Benjamin Curson 1, Jessica C. Ebert 1, Coleen R. Hacker 1, Robert Hartlage 1, Brian Hauser 1, Steve Huang 1, Yuan Jiang 1, Vitali Karpinchyk 1, Mark Koenig 1, Calvin Kong 1, Tom Landers 1, Catherine Le 1, Jia Liu 1, Celeste E. McBride 1, Matt Morenzoni 1, Robert E. Morey 3, Karl Mutch 1, Helena Perazich 1, Kimberly Perry 1, Brock A. Peters 1, Joe Peterson 1, Charit L. Pethiyagoda 1, Kaliprasad Pothuraju 1, Claudia Richter 1, Abraham M. Rosenbaum 4, Shaunak Roy 1, Jay Shafto 1, Uladzislau Sharanhovich 1, Karen W. Shannon 5, Conrad G. Sheppy 1, Michel Sun 1, Joseph V. Thakuria 4, Anne Tran 1, Dylan Vu 1, Alexander Wait Zaranek 4, Xiaodi Wu 6, Snezana Drmanac 1, Arnold R. Oliphant 1, William C. Banyai 1, Bruce Martin 1, Dennis G. Ballinger 1*, George M. Church 4, Clifford A. Reid 1
    1 Complete Genomics, Inc., 2071 Stierlin Court, Mountain View, CA 94043, USA.
    2 Complete Genomics, Inc., 2071 Stierlin Court, Mountain View, CA 94043, USA.; Present address: Ion Torrent Systems, San Francisco, CA, USA.
    3 Complete Genomics, Inc., 2071 Stierlin Court, Mountain View, CA 94043, USA.; Present address: San Diego State University, San Diego, CA, USA.
    4 Department of Genetics, Harvard Medical School, Cambridge, MA, USA.
    5 Complete Genomics, Inc., 2071 Stierlin Court, Mountain View, CA 94043, USA.; Present address: Life Technologies, Carlsbad, CA, USA.
    6 School of Medicine, Washington University, St. Louis, St. Louis, MO, USA.


    * To whom correspondence should be addressed.
    Radoje Drmanac , E-mail: [email protected]
    Dennis G. Ballinger , E-mail: [email protected]


    These authors contributed equally to this work.

    Genome sequencing of large numbers of individuals promises to advance the understanding, treatment, and prevention of human diseases, among other applications. We describe a genome sequencing platform that achieves efficient imaging and low reagent consumption with combinatorial probe anchor ligation (cPAL) chemistry to independently assay each base from patterned nanoarrays of self-assembling DNA nanoballs (DNBs). We sequenced three human genomes with this platform, generating an average of 45- to 87-fold coverage per genome and identifying 3.2 to 4.5 million sequence variants per genome. Validation of one genome data set demonstrates a sequence accuracy of about 1 false variant per 100 kilobases. The high-accuracy, affordable cost of $4,400 for sequencing consumables and scalability of this platform enable complete human genome sequencing for the detection of rare variants in large-scale genetic studies.
    Last edited by wuhoucdc; 11-11-2009, 01:52 PM. Reason: Change the title

  • #2
    Hi Wuhoucdc,

    For some more information about this paper, I encourage you to review our website (http://www.completegenomics.com/data...ngResults.aspx).

    If you have some specific questions, we would be happy to address. You can contact us at [email protected] for general information or at [email protected] for more detailed analysis support.

    Regards,
    Dione

    Comment


    • #3
      Hi Dione,

      After read more carefully on your website about this new technology, I think it will be applied rapidly on various domains. I hope this technology will bring us new chance among human genomics. Thank you.

      Best,

      Wuhoucdc

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Essential Discoveries and Tools in Epitranscriptomics
        by seqadmin




        The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...
        04-22-2024, 07:01 AM
      • seqadmin
        Current Approaches to Protein Sequencing
        by seqadmin


        Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
        04-04-2024, 04:25 PM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, 04-11-2024, 12:08 PM
      0 responses
      59 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-10-2024, 10:19 PM
      0 responses
      57 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-10-2024, 09:21 AM
      0 responses
      51 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-04-2024, 09:00 AM
      0 responses
      55 views
      0 likes
      Last Post seqadmin  
      Working...
      X